Join BioOhio and Project Medtech for a fun networking social in Cleveland, Ohio! This event will bring the region’s life science community together for networking and connecting. We’ll be at local gem and member Saucy Brew!

The U.S. healthcare market is in a continuous state of flux and uncertainty. Now more than ever, it’s imperative that pharmaceutical manufacturers partner with emerging vendors to overcome the unique market access challenges of rare disease and gene/cell therapies to avoid pitfalls and to drive a successful product launch. During this webinar, our experts will provide in-depth insights on commercialization strategy, distribution models and demonstrating therapeutic value of Rare Disease & Gene/Cell therapies for patients, payers, and providers. This event features member Michael Baldzicki, Chief Brand Officer, AscellaHealth.

Join us as Agilent technical experts provide you with the valuable tools needed to accelerate your instrument towards unmatched performance and productivity. This seminar is designed to give you real-world knowledge that can be applied immediately in your lab. You are invited to join us for a half day or you can attend both the LC and the GC sessions. Registration is free but seating is limited. ** There are three events touring the state of Ohio: Southwest Ohio 9/20 (Mason) | Central Ohio 9/21 (Powell) | Northeast Ohio 9/22 (Independence) **

Please join Bristol Myers Squibb (BMS) for a virtual policy forum on the Inflation Reduction Act. The forum will bring together patient and professional advocates with internal BMS experts to deliver a brief overview and timeline of implementation of the healthcare policies in the new law.

Presented by The Alliance for Regenerative Medicine, The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Save the dates for next year’s conference October 11-13, 2022!

Xavier University is pleased to host Catherine Pearce, COO of CinCor Pharma, and Dr. Robert Preti, Principal at Robert A Preti Advisory and serving as Managing Director of Current Biologics, for a discussion on how they have transformed healthcare and how you can contribute regardless of your background to the development of innovative and curative therapies. This keynote panel will be followed by a networking event to learn more about the many roles available for those interested in a career in the clinical sciences, especially those roles that don’t require a lab coat. The event is open to all.

The Cell & Gene therapy market is poised to undergo significant growth over the next 2-5yrs growing from a $1B market in 2018 to a ~$9B market by 2025. However, we anticipate finding qualified talent will become a critical roadblock to bringing innovative new therapies to market. Kelly Science & Clinical, the 2nd largest Science staffing agency, is taking the lead to address this challenge head-on by hosting the second installment of (Ex)2: The Expert Exchange Series, Accelerating Cell & Gene Therapy Careers. We will bring together well-known industry experts along with our own experts to discuss the growing talent needs and share with candidates insights and job opportunities for them to ride this wave to accelerate their careers in cell & gene therapy.

The Association of Food and Drug Officials (AFDO) and the Regulatory Affairs Professionals Society (RAPS) have come together to support sharing, collaboration, and learning across the global healthcare products community. With a focus on fostering open discussions of the most pressing issues facing the industry, the AFDO/RAPS Healthcare Products Collaborative will carry on Xavier Heath’s legacy of delivering the Combination Products Summit. The AFDO/RAPS Healthcare Products Collaborative combination products community continues to be led by top FDA officials and worldwide industry leaders who built the framework for the regulatory landscape of combination products. This global community drives innovation and navigates the complexities specific to the world of combination products, resulting in the delivery of safe, effective, and high-quality products to the patients who need them.

The Advancing Healthcare Innovation Summit (AHIS2022) is a major healthcare conference and exhibit showcasing the latest innovations related to healthcare and medical sciences. AHIS2022 is a networking conference for all stakeholders in healthcare innovations.

The Association of Food and Drug Officials (AFDO) and the Regulatory Affairs Professionals Society (RAPS) have come together to support sharing, collaboration, and learning across the global healthcare products community. With a focus on fostering open discussions of the most pressing issues facing the industry, the AFDO/RAPS Healthcare Products Collaborative will carry on Xavier Heath’s legacy of delivering Pharmalink in 2022. At PharmaLink, we work to find solutions that will increase confidence in product quality throughout your products’ life cycle management and global supply chain. We do this by aligning with the strategic priorities of the FDA and industry – and by helping participants create network links to drive compliant innovations. The solutions might not be evident within our companies, or our industry, so we explore beyond our industry – beyond borders and beyond comfort zones.